Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects

Area of Science:

• Immunology
• Metabolism
• Mitochondrial Biology

Background:

• NLRP3 inflammasome activation is linked to metabolic dysfunction.
• Intermittent fasting may improve diseases associated with NLRP3 inflammasome activation.
• Mitochondrial dysfunction exacerbates NLRP3 inflammasome activation.

Purpose of the Study:

• To investigate if fasting blunts inflammasome activation.
• To determine if fasting enhances mitochondrial integrity through sirtuin pathways.
• To explore the role of SIRT3 in regulating NLRP3 inflammasome activation.

Main Methods:

• A clinical study involving 19 healthy volunteers undergoing a 24-hour fast and subsequent refeeding.
• Analysis of NLRP3 inflammasome activation in blood samples from fasted and fed states.
• In vitro studies using human macrophage cell lines and ex vivo leukocyte analysis to assess SIRT3 activity and mitochondrial function.

Main Results:

• Fasting significantly reduced NLRP3 inflammasome activation compared to the refed state.
• Depletion of SIRT3 increased inflammasome activation and mitochondrial reactive oxygen species (ROS) production.
• SIRT3 activation, both genetic and pharmacologic, attenuated NLRP3 activity and improved mitochondrial function in various human cell types.

Conclusions:

• Nutrient availability regulates the NLRP3 inflammasome through SIRT3-dependent mitochondrial homeostasis.
• Deacetylase-dependent inflammasome attenuation presents a potential therapeutic strategy for human diseases.
• Fasting-induced improvements in mitochondrial integrity may be mediated by SIRT3.